Healthcare ALT

Active

[ezcol_1fifth]

01_ACTB — ACT Biotech
Targeted, orally available cancer drugs
USA

[/ezcol_1fifth] [ezcol_1fifth]

Axellis — Axellis
Radiation oncology solutions
United Kingdom

[/ezcol_1fifth][ezcol_1fifth]

BioMAX
Bioinformatics software solutions
Germany

[/ezcol_1fifth] [ezcol_1fifth]

Curadis — Curadis
Drugs against hormone-dependent diseases such as breast cancer
Germany

[/ezcol_1fifth] [ezcol_1fifth_end]

Effrx — EffRx Pharmaceuticals
Commercial stage osteoporosis drug
Switzerland

[/ezcol_1fifth_end] [ezcol_1fifth]

Isarna — Isarna
Selective TGF-β oligonucleotide inhibitors
Germany

[/ezcol_1fifth] [ezcol_1fifth]

lophius — lophius
T cell-based research tools, contract research and diagnostics
Germany

[/ezcol_1fifth] [ezcol_1fifth]

03_Memo — Memo Therapeutics Human antibody repertoire platform
Switzerland
-

[/ezcol_1fifth] [ezcol_1fifth]

multimmune — multimmune
Diagnostic platforms and focused therapies for cancer patients
Germany

[/ezcol_1fifth] [ezcol_1fifth_end]

multimmune — M.O.R.E Medical Solutions GmbH
Orthopaedic and trauma surgery solutions
Germany

[/ezcol_1fifth_end] [ezcol_1fifth]

NeuroProof — NeuroProof
Drug discovery and development services
Germany

[/ezcol_1fifth] [ezcol_1fifth]

06_Pieris — Pieris
Therapeutic proteins
USA

[/ezcol_1fifth] [ezcol_1fifth]

Presidio Pharma — Presidio Pharmaceuticals
Hepatitis C drug
USA

[/ezcol_1fifth] [ezcol_1fifth]

[/ezcol_1fifth] [ezcol_1fifth_end]
[/ezcol_1fifth_end] [ezcol_1fifth]

[/ezcol_1fifth] [ezcol_1fifth]
[/ezcol_1fifth] [ezcol_1fifth]
[/ezcol_1fifth] [ezcol_1fifth]

[/ezcol_1fifth] [ezcol_1fifth_end]

[/ezcol_1fifth_end]

Exited

.

[ezcol_1fifth]

01_Analyticon — AnalytiCon Discovery
Natural product small molecules and analogues libraries
Germany
Exit 2013

[/ezcol_1fifth] [ezcol_1fifth]

Arravasc — ArraVasc
Peripheral balloon catheters
Ireland
Exit 2018
-
-

[/ezcol_1fifth] [ezcol_1fifth]

02_Astex — Astex Pharmaceuticals
Drugs against cancer
USA
Exit 2013
-
-

[/ezcol_1fifth] [ezcol_1fifth]

03_ATTO-TEC — Atto-Tec
Fluorescent dyes
Germany
Exit 2009
-
-

[/ezcol_1fifth] [ezcol_1fifth_end]

06_Biobase — Biobase
Molecular biology databases and tools
Germany
Exit 2012

[/ezcol_1fifth_end] [ezcol_1fifth]

cerbomed — cerbomed
Non-invasive vagus-nerve stimulation device against epilesy
Germany
Exit 2018
-
-

[/ezcol_1fifth] [ezcol_1fifth]

04_Chiracon — Chiracon
Chiral intermediates
Germany
Exit 2008
-
-

[/ezcol_1fifth] [ezcol_1fifth]

05_Corassist — CorAssist Cardiovascular
Medical devices for treatment of heart failure
Israel
Exit 2015

[/ezcol_1fifth] [ezcol_1fifth]

07_Develogen — DeveloGen
Metabolic disorders
Germany
Exit 2009
-
-
-

[/ezcol_1fifth] [ezcol_1fifth_end]

08_Envoy Medical — Envoy Medical
Totally implantable hearing aid
USA
Exit 2007
-
-

[/ezcol_1fifth_end] [ezcol_1fifth]

09_Getemed — Getemed
Vital signs monitors
Germany
Exit 2007
-
-
-

[/ezcol_1fifth] [ezcol_1fifth]

10_Hybrigenics — Hybrigenics
Drugs against cancer
and screening services
France
Exit 2009 (IPO)
-
-

[/ezcol_1fifth] [ezcol_1fifth]

11_IDM — IDM Pharma
Drugs against cancer
USA
Exit 2007 ("cold" IPO)

[/ezcol_1fifth] [ezcol_1fifth]

MTM — MTM Laboratories
Cancer diagnostics
Germany
Exit 2018

[/ezcol_1fifth] [ezcol_1fifth_end]

MyoScience — MyoScience
Pain treatment devices
USA
Exit 2019

[/ezcol_1fifth_end] [ezcol_1fifth]

04_Neurotech — Neurotech
Ophthalmic diseases
USA
Exit 2016

[/ezcol_1fifth] [ezcol_1fifth]

12_Noxxon — Noxxon Pharma
Drugs against inflammatory and hermatological diseases
Germany
Exit 2007

[/ezcol_1fifth] [ezcol_1fifth]

05_Paratek — Paratek
Drugs against infectious diseases
USA
Exit 2014 (IPO)

[/ezcol_1fifth] [ezcol_1fifth]

13_Philogen — Philogen
Drugs against angiogenesis-related disorders
Italy
Exit 2013

[/ezcol_1fifth] [ezcol_1fifth_end]

Physiotec
Orthopaedics for children
Germany
Exit 2017
-
-

[/ezcol_1fifth_end] [ezcol_1fifth]

14_Sepiatec — Sepiatec
Chromatographic devices (HPLC)
Germany
Exit 2012

[/ezcol_1fifth] [ezcol_1fifth]

[/ezcol_1fifth] [ezcol_1fifth]
[/ezcol_1fifth] [ezcol_1fifth]
[/ezcol_1fifth] [ezcol_1fifth]

[/ezcol_1fifth] [ezcol_1fifth_end]

[/ezcol_1fifth_end]